The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Updates on the risk factors for latent tuberculosis reactivation and their managements
Open accessAbstract
The preventive treatment of latent tuberculosis infection (LTBI) is of great importance for the elimination and control of tuberculosis (TB) worldwide, but existing screening methods for LTBI are still limited in predicting the onset of TB. Previous studies have found that some high-risk factors (including human immunodeficiency virus (HIV), organ transplantation, silicosis, tumor necrosis factor-alpha blockers, close contacts and kidney dialysis) contribute to a significantly increased TB reactivation rate. This article reviews each risk factor's association with TB and approaches to address those factors. Five regimens are currently recommended by the World Health Organization, and no regimen has shown superiority over others. In recent years, studies have gradually narrowed down to the preventive treatment of LTBI for high-risk target groups, such as silicosis patients, organ-transplantation recipients and HIV-infected patients. This review discusses regimens for each target group and compares the efficacy of different regimens. For HIV patients and transplant recipients, isoniazid monotherapy is effective in treating LTBI, but for others, little evidence is available at present.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hao (2015) · doi:10.1002/14651858 · Cited by 11,321
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
Keane, J., Gershon, S., Wise, R. P., Mirabile-Levens, E., Kasznica, J., Schwieterman, W. D., Siegel, J. N., & Braun, M. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011110 · Cited by 3,710
Maini, R., St Clair, E. W., Breedveld, F., Furst, D., Kalden, J., Weisman, M., Smolen, J., Emery, P., Harriman, G., Feldmann, M., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)05246-0 · Cited by 2,345
Jeon, C. Y., & Murray, M. B. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050152 · Cited by 1,486
Menzies, D., Pai, M., & Comstock, G. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-5-200703060-00006 · Cited by 984
Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection
Sterling, T. R., Villarino, M. E., Borisov, A. S., Shang, N., Gordin, F., Bliven-Sizemore, E., Hackman, J., Hamilton, C. D., Menzies, D., Kerrigan, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1104875 · Cited by 977
Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection
(2016) · Pediatric Clinical Practice Guidelines & Policies · doi:10.1542/9781610020190-part06-targeted · Cited by 920
Interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic review
Pai, M., Riley, L. W., & Colford, J. M. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01206-x · Cited by 913
Treatment of latent tuberculosis infection in HIV infected persons
Akolo, C., Adetifa, I., Shepperd, S., & Volmink, J. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000171.pub3 · Cited by 713
Newsom, S. W. B. (2006) · Journal of Hospital Infection · doi:10.1016/j.jhin.2006.06.003 · Cited by 635
Cited by
Drain, P. K., Bajema, K. L., Dowdy, D., Dheda, K., Naidoo, K., Schumacher, S. G., Ma, S., Meermeier, E., Lewinsohn, D. M., & Sherman, D. R. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00021-18 · Cited by 565
Anti-tuberculosis treatment strategies and drug development: challenges and priorities
Dartois, V. A., & Rubin, E. J. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00731-y · Cited by 490
Bacterial Longevity Requires Protein Synthesis and a Stringent Response
Yin, L., Ma, H., Nakayasu, E. S., Payne, S. H., Morris, D. R., & Harwood, C. S. (2019) · mBio · doi:10.1128/mbio.02189-19 · Cited by 31
Long‐term exposure to indoor air pollution and risk of tuberculosis
Patel, V., Foster, A., Salem, A., Kumar, A., Kumar, V., Biswas, B., Mirsaeidi, M., & Kumar, N. (2021) · Indoor Air · doi:10.1111/ina.12756 · Cited by 27
Bacterial longevity requires protein synthesis and a stringent response
Yin, L., Ma, H., Nakayasu, E. S., Payne, S. H., Morris, D. R., & Harwood, C. S. (2019) · doi:10.1101/628826
Metadata
- Authors
- Ai, J.-W., Ruan, Q.-L., Liu, Q.-H., & Zhang, W.-H.
- Venue
- Emerging Microbes & Infections
- Publisher
- Informa UK Limited
- Published
- 2016-01
- Volume
- 5
- Issue
- 1
- Pages
- 1-8
- ISSN
- 2222-1751 (ISSN-L)
- OpenAlex
- W2273040868
- Cited by
- 298
- References
- 82
- FWCI
- 23.52
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Updates on the risk factors for latent tuberculosis reactivation and their managements. https://app.cochat.ai/papers/10.1038/emi.2016.10
- The paper
- Ai, J.-W., Ruan, Q.-L., Liu, Q.-H., & Zhang, W.-H. (2016). Updates on the risk factors for latent tuberculosis reactivation and their managements. Emerging Microbes & Infections. https://doi.org/10.1038/emi.2016.10
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.